Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIICompletedD-0481-2024

Drug recall · May 8, 2024

Valacyclovir Tablets USP recall

Why: Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Valacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-4275-77

Lots / codes

Lot #: 3183269, Exp. Date May 2025; 3157326, Exp. date June 2024

Quantity
143,230 bottles
Company
Viatris Inc, Canonsburg, PA
Distribution
Nationwide within the united states
Initiated
April 25, 2024 · Voluntary: Firm initiated
Classified
May 2, 2024
Reported
May 8, 2024
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Valacyclovir

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.